Illumina 2026年3月3日 Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina 2026年3月3日 Is Illumina’s (ILMN) TruPath Rare Disease Push Reframing Its Clinical Sequencing Investment Narrative? - simplywall.st
Illumina 2026年3月3日 Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Illumina 2026年3月2日 Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing - Yahoo Finance
Illumina 2026年2月28日 Illumina Deepens Clinical Genomics Role With TruPath Genome And FSU Deal - simplywall.st
Illumina 2026年2月27日 Illumina jumps 5.5% as momentum builds after upbeat outlook and multiomics push - Quiver Quantitative
Illumina 2026年2月27日 Illumina Partners with SPT Labtech, Takara Bio on Automated Sample Prep and Spatial Transcriptomics - GEN - Genetic Engineering and Biotechnology News
Illumina 2026年2月27日 Illumina Partners with SPT Labtech, Takara Bio on Automated Sample Prep and Spatial Transcriptomics - GEN - Genetic Engineering and Biotechnology News
Illumina 2026年2月27日 Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics - PR Newswire APAC - PR Newswire Asia
Illumina 2026年2月27日 Illumina: Competitive Pressures Mounting but 2026 Revenue Targets Still Intact, Justifying a Hold Rating - TipRanks
Illumina 2026年2月27日 Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - Illumina
Illumina 2026年2月27日 Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - PR Newswire
Illumina 2026年2月27日 Florida lab uses genome sequencing to diagnose children with rare diseases - Stock Titan
Illumina 2026年2月27日 Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - Yahoo Finance
Illumina 2026年2月27日 Primecap Management Co. CA Sells 73,220 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina 2026年2月27日 Illumina Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily